Annual FCF
-$18.75 M
-$7.16 M-61.77%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual free cash flow is -$18.75 million, with the most recent change of -$7.16 million (-61.77%) on December 31, 2023.
- During the last 3 years, DMAC annual FCF has fallen by -$9.52 million (-103.12%).
- DMAC annual FCF is now -9146.55% below its all-time high of -$202.80 thousand, reached on December 31, 2004.
Performance
DMAC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$4.48 M
+$40.00 K+0.89%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly free cash flow is -$4.48 million, with the most recent change of +$40.00 thousand (+0.89%) on September 30, 2024.
- Over the past year, DMAC quarterly FCF has increased by +$328.00 thousand (+6.82%).
- DMAC quarterly FCF is now -1342.10% below its all-time high of $360.60 thousand, reached on September 30, 2010.
Performance
DMAC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$19.48 M
+$328.00 K+1.66%
September 30, 2024
Summary
- As of February 7, 2025, DMAC TTM free cash flow is -$19.48 million, with the most recent change of +$328.00 thousand (+1.66%) on September 30, 2024.
- Over the past year, DMAC TTM FCF has dropped by -$1.74 million (-9.81%).
- DMAC TTM FCF is now -9923.16% below its all-time high of -$194.30 thousand, reached on March 31, 2007.
Performance
DMAC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
DMAC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.8% | +6.8% | -9.8% |
| 3 y3 years | -103.1% | -47.0% | -55.5% |
| 5 y5 years | -226.3% | -47.0% | -55.5% |
DMAC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -61.8% | at low | -86.3% | +32.8% | -68.0% | +4.2% |
| 5 y | 5-year | -106.0% | at low | -430.7% | +32.8% | -181.4% | +4.2% |
| alltime | all time | -9146.5% | at low | -1342.1% | +32.8% | -9923.2% | +4.2% |
DiaMedica Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.48 M(-0.9%) | -$19.48 M(-1.7%) |
| Jun 2024 | - | -$4.52 M(-32.2%) | -$19.80 M(-2.5%) |
| Mar 2024 | - | -$6.66 M(+74.6%) | -$20.32 M(+8.4%) |
| Dec 2023 | -$18.75 M(+61.8%) | -$3.81 M(-20.6%) | -$18.75 M(+5.7%) |
| Sep 2023 | - | -$4.81 M(-4.5%) | -$17.73 M(+15.7%) |
| Jun 2023 | - | -$5.03 M(-1.2%) | -$15.33 M(+19.8%) |
| Mar 2023 | - | -$5.10 M(+82.1%) | -$12.80 M(+10.4%) |
| Dec 2022 | -$11.59 M(-5.6%) | -$2.80 M(+16.4%) | -$11.59 M(-0.1%) |
| Sep 2022 | - | -$2.40 M(-3.9%) | -$11.61 M(-5.3%) |
| Jun 2022 | - | -$2.50 M(-35.6%) | -$12.25 M(+3.5%) |
| Mar 2022 | - | -$3.89 M(+38.3%) | -$11.84 M(-3.5%) |
| Dec 2021 | -$12.27 M(+33.0%) | -$2.81 M(-7.8%) | -$12.27 M(-2.0%) |
| Sep 2021 | - | -$3.05 M(+45.6%) | -$12.52 M(+5.9%) |
| Jun 2021 | - | -$2.09 M(-51.6%) | -$11.82 M(+11.8%) |
| Mar 2021 | - | -$4.32 M(+41.2%) | -$10.57 M(+14.5%) |
| Dec 2020 | -$9.23 M(+1.4%) | -$3.06 M(+30.4%) | -$9.23 M(+14.9%) |
| Sep 2020 | - | -$2.35 M(+178.1%) | -$8.04 M(+16.1%) |
| Jun 2020 | - | -$844.00 K(-71.7%) | -$6.92 M(-22.7%) |
| Mar 2020 | - | -$2.98 M(+59.8%) | -$8.95 M(-1.7%) |
| Dec 2019 | -$9.10 M(+58.4%) | -$1.86 M(+51.4%) | -$9.10 M(-0.2%) |
| Sep 2019 | - | -$1.23 M(-57.1%) | -$9.12 M(-6.4%) |
| Jun 2019 | - | -$2.87 M(-8.4%) | -$9.75 M(+23.2%) |
| Mar 2019 | - | -$3.13 M(+66.1%) | -$7.91 M(+37.7%) |
| Dec 2018 | -$5.75 M(+46.5%) | -$1.89 M(+1.5%) | -$5.75 M(+18.5%) |
| Sep 2018 | - | -$1.86 M(+80.0%) | -$4.85 M(+32.0%) |
| Jun 2018 | - | -$1.03 M(+6.8%) | -$3.67 M(-9.7%) |
| Mar 2018 | - | -$967.00 K(-2.3%) | -$4.07 M(+3.7%) |
| Dec 2017 | -$3.92 M(+31.0%) | -$990.10 K(+45.0%) | -$3.92 M(-6.7%) |
| Sep 2017 | - | -$682.90 K(-52.1%) | -$4.20 M(-5.6%) |
| Jun 2017 | - | -$1.43 M(+73.2%) | -$4.45 M(+30.1%) |
| Mar 2017 | - | -$823.20 K(-35.3%) | -$3.42 M(+14.3%) |
| Dec 2016 | -$2.99 M(+91.1%) | -$1.27 M(+36.5%) | -$2.99 M(+32.1%) |
| Sep 2016 | - | -$931.60 K(+134.8%) | -$2.27 M(+49.3%) |
| Jun 2016 | - | -$396.80 K(+0.7%) | -$1.52 M(-6.3%) |
| Mar 2016 | - | -$394.20 K(-27.5%) | -$1.62 M(+3.4%) |
| Dec 2015 | -$1.57 M | -$543.40 K(+196.5%) | -$1.57 M(+36.7%) |
| Sep 2015 | - | -$183.30 K(-63.2%) | -$1.15 M(-66.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$498.60 K(+46.1%) | -$3.43 M(+15.4%) |
| Mar 2015 | - | -$341.30 K(+177.7%) | -$2.97 M(-21.5%) |
| Dec 2014 | -$3.79 M(-32.8%) | -$122.90 K(-95.0%) | -$3.79 M(-8.6%) |
| Sep 2014 | - | -$2.47 M(+5812.2%) | -$4.14 M(+46.0%) |
| Jun 2014 | - | -$41.70 K(-96.4%) | -$2.84 M(-42.0%) |
| Mar 2014 | - | -$1.16 M(+140.9%) | -$4.89 M(-13.2%) |
| Dec 2013 | -$5.64 M(+1.6%) | -$480.30 K(-58.5%) | -$5.64 M(-14.8%) |
| Sep 2013 | - | -$1.16 M(-44.7%) | -$6.62 M(-10.9%) |
| Jun 2013 | - | -$2.10 M(+10.2%) | -$7.43 M(+9.9%) |
| Mar 2013 | - | -$1.90 M(+30.2%) | -$6.76 M(+21.9%) |
| Dec 2012 | -$5.55 M(+57.8%) | -$1.46 M(-25.7%) | -$5.55 M(+3.0%) |
| Sep 2012 | - | -$1.97 M(+37.5%) | -$5.39 M(+26.5%) |
| Jun 2012 | - | -$1.43 M(+107.4%) | -$4.26 M(+20.2%) |
| Mar 2012 | - | -$689.40 K(-46.9%) | -$3.54 M(+0.7%) |
| Dec 2011 | -$3.52 M(+44.4%) | -$1.30 M(+55.0%) | -$3.52 M(+27.4%) |
| Sep 2011 | - | -$838.20 K(+17.5%) | -$2.76 M(+76.8%) |
| Jun 2011 | - | -$713.40 K(+7.4%) | -$1.56 M(-44.0%) |
| Mar 2011 | - | -$664.40 K(+22.1%) | -$2.79 M(+14.6%) |
| Dec 2010 | -$2.43 M(+8.7%) | -$544.30 K(-250.9%) | -$2.43 M(+1.5%) |
| Sep 2010 | - | $360.60 K(-118.6%) | -$2.40 M(-28.3%) |
| Jun 2010 | - | -$1.94 M(+529.1%) | -$3.35 M(+62.3%) |
| Mar 2010 | - | -$308.70 K(-39.3%) | -$2.06 M(-8.0%) |
| Dec 2009 | -$2.24 M(+44.3%) | -$508.40 K(-13.3%) | -$2.24 M(+22.8%) |
| Sep 2009 | - | -$586.40 K(-10.8%) | -$1.82 M(-8.6%) |
| Jun 2009 | - | -$657.20 K(+35.0%) | -$2.00 M(-1.1%) |
| Mar 2009 | - | -$486.80 K(+422.3%) | -$2.02 M(+30.0%) |
| Dec 2008 | -$1.55 M(+2.8%) | -$93.20 K(-87.7%) | -$1.55 M(-9.0%) |
| Sep 2008 | - | -$758.20 K(+11.7%) | -$1.71 M(-3.0%) |
| Jun 2008 | - | -$678.70 K(+3042.1%) | -$1.76 M(+31.5%) |
| Mar 2008 | - | -$21.60 K(-91.3%) | -$1.34 M(-11.4%) |
| Dec 2007 | -$1.51 M(+65.9%) | -$247.00 K(-69.5%) | -$1.51 M(+19.6%) |
| Sep 2007 | - | -$810.40 K(+214.2%) | -$1.26 M(+179.2%) |
| Jun 2007 | - | -$257.90 K(+32.7%) | -$452.20 K(+132.7%) |
| Mar 2007 | - | -$194.30 K | -$194.30 K |
| Dec 2006 | -$910.10 K(+0.2%) | - | - |
| Dec 2005 | -$908.20 K(+347.8%) | - | - |
| Dec 2004 | -$202.80 K | - | - |
FAQ
- What is DiaMedica Therapeutics annual free cash flow?
- What is the all time high annual FCF for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual FCF year-on-year change?
- What is DiaMedica Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly FCF year-on-year change?
- What is DiaMedica Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics TTM FCF year-on-year change?
What is DiaMedica Therapeutics annual free cash flow?
The current annual FCF of DMAC is -$18.75 M
What is the all time high annual FCF for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual free cash flow is -$202.80 K
What is DiaMedica Therapeutics annual FCF year-on-year change?
Over the past year, DMAC annual free cash flow has changed by -$7.16 M (-61.77%)
What is DiaMedica Therapeutics quarterly free cash flow?
The current quarterly FCF of DMAC is -$4.48 M
What is the all time high quarterly FCF for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly free cash flow is $360.60 K
What is DiaMedica Therapeutics quarterly FCF year-on-year change?
Over the past year, DMAC quarterly free cash flow has changed by +$328.00 K (+6.82%)
What is DiaMedica Therapeutics TTM free cash flow?
The current TTM FCF of DMAC is -$19.48 M
What is the all time high TTM FCF for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high TTM free cash flow is -$194.30 K
What is DiaMedica Therapeutics TTM FCF year-on-year change?
Over the past year, DMAC TTM free cash flow has changed by -$1.74 M (-9.81%)